Who Owns Amphastar Pharmaceuticals Stock?
NASDAQ: AMPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 67.62%
- Held by insiders
- 31.01%
- Institutional holders
- 312
- Institutions 67.6%
- Insiders 31.0%
- Public and other 1.4%
Who owns Amphastar Pharmaceuticals stock?
Institutional investors own about 67.6% of Amphastar Pharmaceuticals's shares, spread across 312 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 31.01% of AMPH.
The largest institutional holders are Blackrock Inc. (12.25%), Dimensional Fund Advisors LP (5.59%) and State Street Corporation (3.92%). Together, the top 10 institutions control 39.9% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their AMPH positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AMPH
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 5.22M | 12.25% | -3.6% |
| Dimensional Fund Advisors LP | 2.38M | 5.59% | +3.4% |
| State Street Corporation | 1.67M | 3.92% | +1.9% |
| American Century Companies Inc | 1.59M | 3.72% | +34.7% |
| Vanguard Capital Management LLC | 1.48M | 3.47% | -4.0% |
| Marshall Wace LLP | 1.07M | 2.50% | +4.0% |
| Geode Capital Management, LLC | 970.45K | 2.28% | +0.1% |
| Fuller & Thaler Asset Management Inc. | 949.24K | 2.23% | -32.0% |
| Shaw D.E. & Co., Inc. | 887.05K | 2.08% | +33.3% |
| Vanguard Portfolio Management LLC | 809.57K | 1.90% | +2.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AMPH
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 1.87M | 4.39% |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 1.30M | 3.06% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.06M | 2.48% |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 902.74K | 2.12% |
| iShares Trust-iShares Russell 2000 ETF | 839.37K | 1.97% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 596.08K | 1.40% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 391.08K | 0.92% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 311.76K | 0.73% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 305.99K | 0.72% |
| iShares Trust-iShares Russell 2000 Value ETF | 305.36K | 0.72% |
Frequently asked questions
Who is the largest shareholder of Amphastar Pharmaceuticals?
Blackrock Inc. is the largest institutional shareholder of AMPH, owning 12.25% of shares outstanding (5.22M shares) as of its latest 13F filing.
What percentage of Amphastar Pharmaceuticals is owned by institutions?
Institutions own about 67.6% of AMPH shares and 98.0% of the public float.
How much of Amphastar Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 31.01% of AMPH shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.